Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
r-SAK in Acute Myocardial Infarction (OPTIMA-5)
NCT05023681Phase 4Completed
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Oct 2021
- Primary completion
- Aug 2022
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of staphylokinase in ST elevation myocardial infarction (STEMI), sponsored by Jiangsu Provincial People's Hospital. Started Oct 2021; status: completed.
02
Drugs
staphylokinase
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT05023681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05023681.